Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pre-Eclampsia | 3 | 2023 | 57 | 2.200 |
Why?
|
Myocardial Infarction | 2 | 2021 | 221 | 1.280 |
Why?
|
Diabetes, Gestational | 2 | 2023 | 46 | 1.110 |
Why?
|
Particulate Matter | 2 | 2017 | 49 | 1.080 |
Why?
|
Quality of Life | 2 | 2019 | 459 | 1.040 |
Why?
|
Florida | 11 | 2023 | 358 | 0.990 |
Why?
|
Mass Screening | 2 | 2019 | 427 | 0.980 |
Why?
|
Pregnancy | 11 | 2023 | 1503 | 0.970 |
Why?
|
Environmental Exposure | 2 | 2017 | 207 | 0.960 |
Why?
|
Uterine Rupture | 1 | 2023 | 4 | 0.950 |
Why?
|
Risk Factors | 14 | 2023 | 3414 | 0.940 |
Why?
|
HIV Infections | 8 | 2021 | 2207 | 0.900 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 628 | 0.890 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2022 | 19 | 0.870 |
Why?
|
Premature Birth | 1 | 2023 | 71 | 0.870 |
Why?
|
Bayes Theorem | 3 | 2023 | 91 | 0.840 |
Why?
|
Pregnancy Complications | 1 | 2023 | 132 | 0.840 |
Why?
|
Bronchitis, Chronic | 1 | 2021 | 15 | 0.820 |
Why?
|
Viral Load | 3 | 2020 | 300 | 0.740 |
Why?
|
Kidney Failure, Chronic | 2 | 2019 | 231 | 0.730 |
Why?
|
Aluminum | 2 | 2017 | 34 | 0.730 |
Why?
|
Pregnancy Trimester, First | 2 | 2017 | 24 | 0.730 |
Why?
|
Humans | 39 | 2023 | 34853 | 0.710 |
Why?
|
Peritoneal Dialysis | 1 | 2019 | 8 | 0.700 |
Why?
|
Female | 27 | 2023 | 19873 | 0.700 |
Why?
|
Carbon | 2 | 2017 | 95 | 0.680 |
Why?
|
Pregnant Women | 1 | 2019 | 48 | 0.660 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2019 | 67 | 0.660 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 465 | 0.660 |
Why?
|
Models, Statistical | 2 | 2016 | 171 | 0.650 |
Why?
|
Adult | 18 | 2023 | 11034 | 0.650 |
Why?
|
Lead | 1 | 2019 | 87 | 0.640 |
Why?
|
Renal Dialysis | 1 | 2019 | 119 | 0.640 |
Why?
|
Impulsive Behavior | 1 | 2018 | 44 | 0.630 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2019 | 99 | 0.620 |
Why?
|
Young Adult | 12 | 2023 | 4012 | 0.610 |
Why?
|
Abruptio Placentae | 1 | 2017 | 1 | 0.610 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 143 | 0.590 |
Why?
|
Enterobacteriaceae Infections | 3 | 2021 | 11 | 0.590 |
Why?
|
Adolescent | 16 | 2022 | 5035 | 0.570 |
Why?
|
Stroke | 1 | 2019 | 274 | 0.540 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 195 | 0.540 |
Why?
|
Infant Mortality | 2 | 2012 | 57 | 0.530 |
Why?
|
Pregnancy Trimesters | 1 | 2014 | 15 | 0.520 |
Why?
|
Income | 1 | 2016 | 135 | 0.520 |
Why?
|
Infant, Newborn | 5 | 2023 | 871 | 0.520 |
Why?
|
Health Behavior | 1 | 2019 | 491 | 0.510 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2016 | 214 | 0.510 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 260 | 0.500 |
Why?
|
Social Class | 1 | 2016 | 228 | 0.480 |
Why?
|
Feeding Behavior | 1 | 2018 | 418 | 0.480 |
Why?
|
Cross-Sectional Studies | 11 | 2023 | 2561 | 0.460 |
Why?
|
Acute Coronary Syndrome | 2 | 2023 | 35 | 0.460 |
Why?
|
Exercise | 1 | 2018 | 524 | 0.450 |
Why?
|
After-Hours Care | 1 | 2012 | 5 | 0.440 |
Why?
|
Air Pollution, Indoor | 2 | 2021 | 40 | 0.390 |
Why?
|
Middle Aged | 9 | 2020 | 9642 | 0.370 |
Why?
|
Odds Ratio | 3 | 2017 | 517 | 0.370 |
Why?
|
Prevalence | 5 | 2022 | 1425 | 0.360 |
Why?
|
Kuwait | 2 | 2019 | 3 | 0.360 |
Why?
|
Obesity | 2 | 2021 | 965 | 0.350 |
Why?
|
Hypertension | 1 | 2016 | 770 | 0.340 |
Why?
|
Retrospective Studies | 7 | 2023 | 1961 | 0.330 |
Why?
|
Male | 15 | 2020 | 18870 | 0.320 |
Why?
|
United States | 7 | 2023 | 3894 | 0.310 |
Why?
|
Anti-HIV Agents | 2 | 2020 | 394 | 0.280 |
Why?
|
Gestational Age | 2 | 2022 | 190 | 0.250 |
Why?
|
Hysterectomy | 1 | 2023 | 29 | 0.240 |
Why?
|
Nutrition Surveys | 2 | 2021 | 228 | 0.240 |
Why?
|
Incidence | 2 | 2017 | 882 | 0.230 |
Why?
|
Educational Status | 2 | 2016 | 295 | 0.220 |
Why?
|
Aged | 3 | 2019 | 6448 | 0.220 |
Why?
|
Cadmium | 1 | 2021 | 56 | 0.210 |
Why?
|
Hypersensitivity | 1 | 2021 | 28 | 0.200 |
Why?
|
Age Distribution | 2 | 2019 | 223 | 0.200 |
Why?
|
Chlamydia | 1 | 2021 | 42 | 0.190 |
Why?
|
Malnutrition | 1 | 2021 | 45 | 0.190 |
Why?
|
Bangladesh | 2 | 2021 | 20 | 0.190 |
Why?
|
Gonorrhea | 1 | 2021 | 31 | 0.190 |
Why?
|
Prospective Studies | 2 | 2021 | 1353 | 0.190 |
Why?
|
Cannabis | 1 | 2022 | 75 | 0.190 |
Why?
|
Triage | 1 | 2020 | 27 | 0.180 |
Why?
|
Cross Infection | 1 | 2020 | 38 | 0.180 |
Why?
|
Intention | 1 | 2020 | 84 | 0.180 |
Why?
|
Fetal Blood | 1 | 2019 | 47 | 0.170 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 106 | 0.170 |
Why?
|
Telomere | 1 | 2019 | 51 | 0.170 |
Why?
|
Models, Theoretical | 1 | 2020 | 210 | 0.170 |
Why?
|
Continuity of Patient Care | 1 | 2020 | 90 | 0.170 |
Why?
|
Risk-Taking | 2 | 2020 | 435 | 0.170 |
Why?
|
Self Efficacy | 1 | 2020 | 173 | 0.170 |
Why?
|
Employment | 1 | 2019 | 73 | 0.170 |
Why?
|
Emigrants and Immigrants | 1 | 2020 | 125 | 0.170 |
Why?
|
Vaccination | 1 | 2020 | 259 | 0.170 |
Why?
|
Linear Models | 1 | 2019 | 253 | 0.160 |
Why?
|
Patient Compliance | 1 | 2020 | 202 | 0.160 |
Why?
|
Child | 4 | 2020 | 2875 | 0.160 |
Why?
|
Overweight | 2 | 2021 | 233 | 0.160 |
Why?
|
Infant | 3 | 2021 | 1014 | 0.150 |
Why?
|
Smoking Cessation | 1 | 2023 | 487 | 0.150 |
Why?
|
Sexual Behavior | 2 | 2020 | 587 | 0.150 |
Why?
|
Cognition | 1 | 2020 | 373 | 0.150 |
Why?
|
Drug Resistance, Viral | 1 | 2016 | 60 | 0.150 |
Why?
|
beta-Lactamases | 3 | 2021 | 33 | 0.150 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 37 | 0.140 |
Why?
|
Papillomavirus Vaccines | 1 | 2018 | 136 | 0.140 |
Why?
|
Substance-Related Disorders | 2 | 2020 | 685 | 0.140 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 790 | 0.140 |
Why?
|
Cesarean Section | 2 | 2012 | 53 | 0.130 |
Why?
|
Parents | 1 | 2018 | 288 | 0.130 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2018 | 248 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 184 | 0.130 |
Why?
|
Sodium | 1 | 2014 | 101 | 0.130 |
Why?
|
Potassium | 1 | 2014 | 110 | 0.120 |
Why?
|
Magnesium | 1 | 2014 | 95 | 0.120 |
Why?
|
Multivariate Analysis | 1 | 2016 | 570 | 0.120 |
Why?
|
Papillomavirus Infections | 1 | 2018 | 316 | 0.120 |
Why?
|
Rural Population | 1 | 2016 | 253 | 0.120 |
Why?
|
Urban Population | 1 | 2016 | 318 | 0.120 |
Why?
|
Smoking | 3 | 2020 | 903 | 0.120 |
Why?
|
Sex Factors | 2 | 2016 | 859 | 0.120 |
Why?
|
Iron | 1 | 2014 | 204 | 0.110 |
Why?
|
Aged, 80 and over | 1 | 2019 | 2333 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 284 | 0.110 |
Why?
|
Logistic Models | 1 | 2016 | 894 | 0.110 |
Why?
|
Marital Status | 1 | 2012 | 35 | 0.110 |
Why?
|
Confidence Intervals | 1 | 2012 | 151 | 0.110 |
Why?
|
Delivery, Obstetric | 1 | 2012 | 38 | 0.110 |
Why?
|
Asthma | 1 | 2015 | 363 | 0.100 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 423 | 0.100 |
Why?
|
Time Factors | 2 | 2012 | 1681 | 0.100 |
Why?
|
Fetal Death | 1 | 2010 | 15 | 0.100 |
Why?
|
Twins | 1 | 2010 | 16 | 0.100 |
Why?
|
Fetal Development | 1 | 2010 | 29 | 0.090 |
Why?
|
India | 2 | 2020 | 82 | 0.090 |
Why?
|
Age Factors | 1 | 2012 | 1007 | 0.090 |
Why?
|
Socioeconomic Factors | 3 | 2020 | 1003 | 0.080 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 355 | 0.080 |
Why?
|
Bacterial Proteins | 2 | 2021 | 520 | 0.070 |
Why?
|
Child, Preschool | 2 | 2021 | 1318 | 0.060 |
Why?
|
Health Expenditures | 1 | 2023 | 30 | 0.060 |
Why?
|
Breast Neoplasms | 1 | 2014 | 1426 | 0.060 |
Why?
|
Fetal Macrosomia | 1 | 2021 | 13 | 0.050 |
Why?
|
Cats | 1 | 2021 | 65 | 0.050 |
Why?
|
Birth Weight | 1 | 2021 | 93 | 0.050 |
Why?
|
Biomass | 1 | 2021 | 50 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2021 | 57 | 0.050 |
Why?
|
Dogs | 1 | 2021 | 138 | 0.050 |
Why?
|
Allergens | 1 | 2021 | 58 | 0.050 |
Why?
|
Dust | 1 | 2021 | 51 | 0.050 |
Why?
|
Weight Gain | 1 | 2021 | 128 | 0.050 |
Why?
|
Carbapenems | 1 | 2020 | 8 | 0.050 |
Why?
|
Exploratory Behavior | 1 | 2020 | 72 | 0.050 |
Why?
|
Enterobacteriaceae | 1 | 2020 | 26 | 0.050 |
Why?
|
Health Status | 1 | 2023 | 356 | 0.050 |
Why?
|
Hospitals | 1 | 2020 | 86 | 0.040 |
Why?
|
Ascorbic Acid | 1 | 2019 | 63 | 0.040 |
Why?
|
Fetus | 1 | 2019 | 103 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 424 | 0.040 |
Why?
|
Registries | 1 | 2020 | 330 | 0.040 |
Why?
|
Body Mass Index | 1 | 2021 | 775 | 0.040 |
Why?
|
Emotions | 1 | 2020 | 204 | 0.040 |
Why?
|
Sexual Partners | 1 | 2021 | 308 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2020 | 254 | 0.040 |
Why?
|
Poverty | 1 | 2020 | 316 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2020 | 901 | 0.040 |
Why?
|
Risk | 1 | 2016 | 256 | 0.030 |
Why?
|
Absenteeism | 1 | 2015 | 10 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2020 | 531 | 0.030 |
Why?
|
Texas | 1 | 2016 | 299 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 271 | 0.030 |
Why?
|
Sex Distribution | 1 | 2015 | 212 | 0.030 |
Why?
|
Genotype | 1 | 2016 | 641 | 0.030 |
Why?
|
Needs Assessment | 1 | 2015 | 159 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2015 | 188 | 0.030 |
Why?
|
SEER Program | 1 | 2014 | 87 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 528 | 0.030 |
Why?
|
Survival Rate | 1 | 2014 | 310 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 638 | 0.030 |
Why?
|
Missouri | 1 | 2012 | 7 | 0.030 |
Why?
|
Live Birth | 1 | 2012 | 8 | 0.030 |
Why?
|
Maternal Age | 1 | 2012 | 27 | 0.030 |
Why?
|
Pregnancy in Adolescence | 1 | 2012 | 33 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 707 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2014 | 964 | 0.020 |
Why?
|
Cohort Studies | 1 | 2012 | 1422 | 0.020 |
Why?
|
Models, Biological | 1 | 2010 | 642 | 0.020 |
Why?
|
Animals | 1 | 2021 | 14307 | 0.020 |
Why?
|